Final Results: Regulatory Affairs Pro Global Survey 2025 Exposes Rising Pressures & Hidden Costs

NEW YORK - Sept. 17, 2025 - PRLog -- The final results of the Regulatory Affairs Pro Global Survey 2025 have been released, uncovering the daily struggles of professionals who work behind the scenes to ensure medicines, medical devices, and health products are safe, effective, and accessible. The survey reached more than 500 specialists worldwide, representing pharmaceuticals, biotechnology, medical devices, diagnostics, and emerging health technologies.

The results paint a picture of a workforce under pressure, with challenges that ripple far beyond boardrooms and regulatory offices — ultimately shaping what treatments reach patients, when, and at what cost.

Key Findings – Three Pressing Realities

1. Overload & Burnout – app. 62% of regulatory professionals report exhaustion from constant rule changes, parallel submissions across multiple countries, and rising documentation demands. Burnout isn't just a workplace issue — it risks slowing down approvals that patients depend on.
2. Unpredictable Delays – More than half highlighted inconsistent and lengthy agency review timelines. Each month of delay can mean patients wait longer for life-saving therapies — and companies face mounting costs that eventually drive up drug prices.
3. Budget Pressures & Talent Gaps – app. 48% cited shrinking budgets and severe talent shortages. With smaller teams carrying heavier workloads, companies often struggle to keep projects on track, which contributes to higher development costs and limited access to affordable medicines.

"These results are not just about industry headaches," said Dr. Vlad Reznikov, survey lead and CEO of Pattern of USA Inc. "Every delay, every budget cut, every burnt-out professional has a direct impact on patients — on the affordability of medicines, on access to new treatments, and on the overall cost of healthcare."

The survey also points to a growing need for smarter digital tools, more transparent regulatory pathways, and sustainable workforce planning. As global demand for innovation increases, so does the urgency to address these barriers.

For patients and families worldwide, the stakes are clear: faster approvals mean quicker access to critical treatments; efficient regulatory systems mean lower costs at the pharmacy. The Regulatory Affairs Pro Global Survey 2025 provides a roadmap for understanding these connections — and for driving change that matters to everyone.

The complete findings and detailed analysis are available now on ResearchGate via the corporate page https://patternofusa.com/2025/09/17/survey-2025/ (https://www.researchgate.net/publication/394470856_Challe...)